Presentation ESC 2017

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Presenter: John Eikelboom

August 27, 2017

REGISTER for free or LOG IN to view this content

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Clinical Cardiology

Clinical Pharma

Prevention

Coronary

ACS/AMI

CAD Pharma

Presentation

ESC 2017

Up Next

Presentation ESC 2017

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Presenter: Robert Giugliano

August 28, 2017

More slides +

Presentation ESC 2017

PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease

Presenter: Martin J. Holzmann

August 28, 2017

Presentation ESC 2017

The Viborg Vascular (VIVA) Randomised Screening Trial

Presenter: Jes Lindholt

August 29, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.